Related Experiment Videos
Management of eclampsia
1Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center at Dallas 75235.
Seminars in Perinatology
|April 1, 1994
Summary
Eclampsia management in pregnancy requires careful monitoring. Magnesium sulfate controlled seizures, but aggressive hydralazine use caused fetal distress, highlighting the need for precise medication titration.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Pharmacology
Background:
- Eclampsia is a severe complication of pregnancy characterized by seizures.
- Effective management involves controlling maternal convulsions and stabilizing blood pressure.
Observation:
- A pregnant patient at 34 weeks' gestation presented with eclampsia.
- Magnesium sulfate successfully arrested seizures; however, aggressive hydralazine administration led to profound hypotension.
- This hypotension caused significant fetal bradycardia due to reduced uteroplacental perfusion.
Findings:
- Both maternal blood pressure and fetal status recovered spontaneously.
- Hemoconcentration was noted, prompting conservative fluid management to prevent pulmonary edema.
- Labor was induced successfully, resulting in the delivery of a healthy infant.
Implications:
- This case underscores the critical need for cautious and precise titration of antihypertensive medications during eclampsia management.
- Close maternal and fetal monitoring is essential to detect and manage adverse effects of treatment.
- Successful management involves a multidisciplinary approach, including pharmacologic intervention, vigilant observation, and timely delivery.